<DOC>
	<DOCNO>NCT02428101</DOCNO>
	<brief_summary>This study examine DNA Gastrointestinal Tract cancer patient treat oxaliplatin look variation ( mutation ) ABCG2 gene may lead drug-induced peripheral neuropathy certain patient . The DNA extract patient ' blood sample analyze ABCG2 gene ( G34A , C421A genotypes ) correlate peripheral neuropathy grade .</brief_summary>
	<brief_title>Oxaliplatin - Induced Peripheral Neuropathy Patients With Gastrointestinal Tract Cancer</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>GIT cancer patient treat Oxaliplatincontaining chemotherapy Measurable disease Age 18 year 80 year Pregnant woman History allergic reaction attribute compound similar chemical biologic composition Oxaliplatin . Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement . Neurologic disease patient disease impair neurologic function affect</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>